Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Gross profit as a percentage of revenue
5Y CAGR
-0.8%/yr
Long-term compound
Percentile
P38
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | 95.96% | -0.6% |
| 2024 | 96.51% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | -100.0% |
| 2021 | 100.00% | 0.0% |
| 2020 | 100.00% | 0.0% |
| 2019 | 100.00% | 0.0% |
| 2018 | 100.00% | 0.0% |
| 2017 | 100.00% | 0.0% |
| 2016 | 100.00% | - |